Hepatitis D
Hepatitis D is a viral infection that occurs in people who are infected with Hepatitis B. It can lead to severe liver disease and is characterized by symptoms such as fatigue, jaundice, and abdominal pain.
Chronic Hepatitis Delta: Brelovitug Treatment Study
We are studying a new medication, brelovitug, for people with chronic hepatitis delta infection. The trial aims to see if it works better than waiting for treatment and to evaluate its safety.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you at least 18 years old?
- Are you pregnant or breastfeeding?
- Do you have chronic hepatitis D virus (HDV) infection confirmed by a doctor?
- Are you currently taking medications like tenofovir (TDF or TAF) or entecavir (ETV)?
- Have you had any major liver problems, like liver failure or liver cancer?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Bjt-778
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Umbal - Prof. D-R Stoyan Kirkovich AD
Gastroenterology Department
Kardzhali, Bulgaria
University Multiprofile Hospital For Active Treatment Saint Georgi EAD
Clinic of Gastroenterology
Plovdiv, Bulgaria
Multiprofile Hospital For Active Treatment Hadji Dimitar OOD
Gastroenterology Department
Sliven, Bulgaria
Sponsor: Bluejay Therapeutics Inc.
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.